"Microdosing as an approach to health enhancement has become more common recently, with social media influencers touting its benefits, and even advertisements for certain GLP-1 medications advocating it."
"According to a new RAND study, in 2025 an estimated 10 million U.S. adults microdosed psilocybin, LSD, or MDMA, with psilocybin being the most used psychedelic."
"Among those who used psilocybin in the past year, 69 percent microdosed at least once during that 12-month period, indicating a significant trend in its usage."
"Despite the growing interest in microdosing psychedelics for therapeutic purposes, no research shows it to be effective for enhancing mental-emotional well-being."
Microdosing psychedelics, particularly psilocybin, has surged in popularity, with an estimated 10 million U.S. adults participating in 2025. Despite its prevalence, research shows no effectiveness in enhancing mental-emotional well-being. The practice involves taking sub-perceptual doses to avoid altered states of consciousness. A RAND study revealed that 69 percent of psilocybin users microdosed at least once in the past year, with nearly half of reported psilocybin use involving microdosing. Potency and dosing unpredictability pose risks of consuming higher amounts than intended.
Read at Psychology Today
Unable to calculate read time
Collection
[
|
...
]